About 600 reports

  • Gastrointestinal Drugs Market Competitive Landscape
  • Gastrointestinal Drugs Market Characteristics
  • OTC
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • OTC
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Gastrointestinal Drugs Global Market Report 2018 ##.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following: - Gastrointestinal tract disorders. - Gastrointestinal tract walls disorders. - Gastrointestinal motility disorders. -

  • Gastrointestinal Drug
  • OTC
  • World

Global Gastrointestinal Drugs Market : IGR Snapshots ##. ## Global Gastrointestinal Drugs Market key trends ##. ## Global Gastrointestinal Drugs Market by drug category ##. ## Global Gastrointestinal Drugs Market by route of administration ##. ## Global

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 07. Epidemiology of Gastrointestinal Disorders
  • Global Gastrointestinal OTC Drugs Market
  • OTC
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

World OTC Pharmaceutical Market Forecast 2016-2026: Recent M& A Activity and Prospects for Rx-to-OTC Switching in Cough, Cold and Allergy, Analgesics, Gastrointestinal Medicines, and Other Leading Segments ##.

  • OTC
  • World
  • Market Size
  • Global gastrointestinal OTC drugs market
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET 2015-2020 ($ BILLIONS)
  • OTC
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Rx-to-OTC Switching, Gastrointestinal OTC Products, Key Markets, Market Size ($bn),
  • Rx-to-OTC Switching, Selected Key Brands in the OTC Gastrointestinal Market
  • OTC
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Global supplements for gastrointestinal tract market 2015-2020 ($ millions)
  • Executive summary
  • OTC
  • Pet Food
  • World
  • Market Size
  • Market challenges

However, the continuous use of salicylic acid over the years can result in the damage of the gastrointestinal tract.

  • OTC
  • World
  • Market Size
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.
  • PROBI: PRODUCT OFFERINGS
  • PROBI: BUSINESS SEGMENTATION BY REVENUE 2016

The long-term agreement includes branding and launch of Probi' s gastrointestinal health product Probi Digestis, which is based on Lactobacillus plantarum ##v.

  • OTC
  • World
  • Forecast
  • Hansen Natural Corporation
  • Probi

Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027 ##. ## Overview ##. ## Cough, Cold and Allergy ##. ##. ## Anti-Allergy Products ##. ## Analgesics ##. ##. ## Internal Analgesics ##. ##. ## External Analgesics ##. ## Gastrointestinal ##. ## Dermatological ##. ##. ## Minor Cuts and Wounds ##. ##. ## Acne ##. ##.

  • OTC
  • World
  • Market Size
  • Gastrointestinal OTC Drugs: Market Analysis
  • Gastrointestinal OTC Drugs: Key Brands and Manufacturers
  • OTC
  • GlaxoSmithKline plc
  • Novartis AG
  • Perrigo Company
  • Pfizer Inc.

Organic trace minerals do not interact with oxalate, silicates, fiber, tannin, phylate, or other minerals in the gastrointestinal tract.

  • Animal Feed
  • Functional Food
  • Livestock
  • Nutraceutical
  • OTC
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014 ($ BILLIONS)
  • TAKEDA: YOY REVENUE GROWTH OF PREVACID 2012-2014 ($ BILLIONS)

Offers a wide range of drugs and pharmaceuticals for the treatment of neuroscience and gastrointestinal diseases.

  • OTC
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited

Gastrointestinal Drugs in Late-Stage Development ## Table ## Estimated U. S.

  • Herbal Supplement
  • OTC
  • United States
  • 4.4.4 ENZYME
  • 8.1 GEOGRAPHICAL OUTLOOK - THE LARGEST & THE FASTEST GROWING COUNTRIES

This is driven by the increasing number of people having gastrointestinal problems. ##. ## HOTSPOTS ENDOCRINE HEALTH & DIABETES Background: It is the number one cause of death globally.

  • OTC
  • Amway Corporation
  • Bounty, Inc.
  • Danone SA
  • General Mills, Inc.

The company offers its products in business areas such as anesthesia and pain control, cardiovascular, central nervous system, gastrointestinal infection, oncology, and respiratory.

  • OTC
  • Europe
  • United States
  • Market Size
  • Novartis AG
  • USE OF INNOVATIVE INGREDIENTS

For example, certain manufacturers have used probiotics and enzymes to support the functions of the gastrointestinal tract.

  • OTC
  • World
  • Demand
  • Forecast
  • Market Size
  • Overview: Consumer healthcare market
  • SEGMENTATION OF GLOBAL CONSUMER HEALTHCARE MARKET BY PRODUCTS

FOR INSTANCE, CONSUMERS WHO HAVE MILD GASTROINTESTINAL CONDITIONS USE GASTROINTESTINAL DRUGS SUCH AS LAXATIVES, ANTIDIARRHEALS, AND DIGESTIVES.

  • OTC
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi S.A.
  • Date
  • NEW PRODUCT LAUNCH

The MicroPEARLS spray freezing technology allows for the timely release of these two key nutrients throughout an animal' s gastrointestinal (GI) tract.

  • OTC
  • World
  • Market Size
  • Ajinomoto Co., Inc.
  • Cargill Inc.
  • GLAXOSMITHKLINE PLC CORPORATE SUMMARY

SYSTEMIC TETRACYCLINE MAY CAUSE GASTROINTESTINAL UPSET, NAUSEA, DIARRHEA, AND VAGINAL YEAST INFECTION.

  • OTC
  • Europe
  • World
  • Market Size
  • Galderma S.A.
  • 6.2 Global Oral Care Market Players Segments Comparison
  • 5.3.5 Online Purchase of Oral Care Products

Bodywash Liquidhand Wash Shave Preps Skin Care Hair Care Health Care Oral Care (Toothbrushes, Toothpaste, Other Oral Care, Crest, Oral-B) Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/ Minerals/ Supplements, Other Personal Health Care) Soups Side

  • OTC
  • World
  • Market Size
  • Colgate-Palmolive Company
  • Unilever PLC
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014 ($ BILLIONS)
  • Oncology 12%

INFECTION, NEUROSCIENCE, AND GASTROINTESTINAL RESPIRATORY, INFLAMMATION, AND AUTOIMMUNITY In FY2014, this segment generated $##. ## billion, which was ##. ##% higher than the segment' s revenue in FY2013.

  • Allergy Drug
  • OTC
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.

Gastrointestinal General Physician Georgetown Public Hospital Corporation General Surgery Healthcare Health and Social Care Information Centre Joint Commission International Korea-U. S.

  • OTC
  • Market Size
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard, Inc.

Pharmaceutical: The pharmaceutical segment includes products for areas such as anti-infective, antipsychotic, contraceptive, hematology, gastrointestinal, immunology, infectious diseases, oncology, neurology, pain management, thrombosis, and JOHNSON & JOHNSON BUSINESS OVERVIEW Source: T

  • OTC
  • United States
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Furthermore, there is a growing concern regarding digestive health globally; in a press release from Royal DSM in December 2015, around ##% of global consumers are experiencing some type of gastrointestinal issues.

  • OTC
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.
  • Global vesicular tinea pedis treatment market 2016-2021 ($ millions)
  • Strength: 1 Low; 5 High

The company is focusing on developing new treatments in the areas of dermatology, eye health, gastrointestinal disorders, neurology, and branded generics.

  • OTC
  • World
  • Market Size
  • Valeant Pharmaceuticals International, Inc.
  • Viamet Pharmaceuticals, Inc.

GASTROINTESTINAL DISORDER TREATMENTS ## Antacids ## H## Blockers ## Proton Pump Inhibitors (PPIs) ## GLOBAL MARKET FORECAST FOR THROUGH 2021 ## TABLE ## GLOBAL MARKET FORECAST FOR OTC GASTROINTESTINAL PRODUCTS, THROUGH 2021 ($ MILLIONS) ## OTC DERMATOLOGICAL DRUGS MARKETS 2021 ## SKINCARE AN

  • OTC
  • World